Auditory brainstem evoked potentials in early-treated congenital hypothyroidism

Area of Science:

• Pediatric Endocrinology
• Neurophysiology
• Developmental Neuroscience

Background:

• Congenital hypothyroidism (CH) requires timely treatment to prevent neurodevelopmental deficits.
• Neonatal screening identifies hyperthyrotropinemia, enabling early intervention for CH.
• The long-term impact of early CH treatment on central nervous system (CNS) development requires further investigation.

Purpose of the Study:

• To assess the effect of early CH treatment on CNS development using auditory brainstem evoked potentials (ABEPs).
• To identify electrophysiologic abnormalities in the auditory pathway of infants treated for CH.
• To explore potential correlations between ABEP findings and initial thyroid hormone levels.

Main Methods:

• Auditory brainstem evoked potentials (ABEPs) were recorded in 32 patients diagnosed with hyperthyrotropinemia during neonatal screening.
• Patients included those with congenital hypothyroidism (n=27) and transient hypothyroidism (n=5).
• ABEP parameters, including peripheral and central conduction times, were analyzed.

Main Results:

• Abnormal ABEP tracings were observed in 8 patients (25%), 7 with CH and 1 with transient hypothyroidism.
• Abnormalities included increased peripheral conduction time (wave I prolongation) in 4 patients and increased central conduction time (waves III or V prolongation) in 4 patients.
• Six patients with abnormal ABEPs had lower initial thyroxine levels, despite no increased initial clinical manifestations.

Conclusions:

• Early treatment of CH may not entirely normalize auditory pathway electrophysiology.
• ABEP assessment can reveal subclinical auditory pathway dysfunction in early-treated CH patients.
• Further research is needed to clarify the relationship between ABEP patterns and long-term neurodevelopmental outcomes.